Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ)
- 1 February 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (2) , 261-264
- https://doi.org/10.1016/0277-5379(84)90193-7
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Irreversible binding of reductively activated streptonigrin to nucleic acids in the presence of metalsChemico-Biological Interactions, 1981
- Potential CNS Antitumor Agents VI: Aziridinylbenzoquinones IIIJournal of Pharmaceutical Sciences, 1979
- Potential central nervous system antitumor agents. Aziridinylbenzoquinones. 2Journal of Medicinal Chemistry, 1976
- Studies related to antitumor antibiotics. Part V. Reactions of mitomycin C with DNA examined by ethidium fluorescence assayCanadian Journal of Biochemistry, 1976
- Studies Related to Antitumor Antibiotics. Part VI. Correlation of Covalent Cross-linking of DNA by Bifunctional Aziridinoquinones with their Antineoplastic ActivityCanadian Journal of Chemistry, 1975
- Potential bioreductive alkylating agents. 5. Antineoplastic activity of quinoline-5,8-diones, naphthazarins, and naphthoquinonesJournal of Medicinal Chemistry, 1975
- Mitomycins and Porfiromycin: Chemical Mechanism of Activation and Cross-linking of DNAScience, 1964
- Mitomycin C: Chemical and Biological Studies on AlkylationScience, 1963